The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

M.V. Budzinskaya

Krasnov Research Institute of Eye Diseases

A.V. Shelankova

Research Institute of Eye Diseases

I.V. Andreeva

Research Institute of Eye Diseases

A.A. Plyukhova

Krasnov Research Institute of Eye Diseases

M.A. Afanasyeva

Research Institute of Eye Diseases

Antiangiogenic therapy for types I and II macular neovascularization in age-related macular degeneration


M.V. Budzinskaya, A.V. Shelankova, I.V. Andreeva, A.A. Plyukhova, M.A. Afanasyeva

More about the authors

Journal: Russian Annals of Ophthalmology. 2021;137(5): 7‑13

Views: 1668

Downloaded: 36

To cite this article:

Budzinskaya MV, Shelankova AV, Andreeva IV, Plyukhova AA, Afanasyeva MA. Antiangiogenic therapy for types I and II macular neovascularization in age-related macular degeneration. Russian Annals of Ophthalmology. 2021;137(5):7‑13. (In Russ., In Engl.)

Recommended articles:
Diagnosis and clinical features of non-exudative macu­lar neovascularization. Russian Annals of Ophthalmology. 2023;(1):138-146
Fari­cimab: from research to clinical practice. Russian Annals of Ophthalmology. 2023;(4):115-120
Choroidal neovascularization in central serous chorioretinopathy. Russian Annals of Ophthalmology. 2023;(6):152-157

Email Confirmation

An email was sent to with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.